Effect of octreotide on the pathology of hepatic schistosomiasis

In clinical practice, octreotide (CAS 83150-76-9) has its greatest impact in the management of bleeding varices. The present work is the first one which was undertaken to investigate the possible use of octreotide as an antifibrotic agent and to study its effect on hepatic vasculature in Schistosoma...

Full description

Saved in:
Bibliographic Details
Published in:Arzneimittel-Forschung Vol. 48; no. 8; p. 855
Main Authors: Mansy, S S, Yehia, H A, Hassan, M M, Hassan, E A, Youssef, M M, Hadi, A A, Mackenzie, C D
Format: Journal Article
Language:English
Published: Germany 01-08-1998
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract In clinical practice, octreotide (CAS 83150-76-9) has its greatest impact in the management of bleeding varices. The present work is the first one which was undertaken to investigate the possible use of octreotide as an antifibrotic agent and to study its effect on hepatic vasculature in Schistosoma mansoni infection. The material of this investigation consisted of two groups of albino mice (A, B), subdivided each into normal control, infected control, subgroups treated with octreotide, praziquantel (CAS 55268-74-1), and a combination of octreotide and praziquantel. Groups A and B were sacrificed at the 8th week and the 18th week post infection, respectively. By analysis of the obtained results, octreotide induced a reduction of the portal pressure, the weight of the spleen and the liver, the liver egg load (number of eggs) granuloma size and cellularity, and of the degree of hepatic fibrosis quantified by serum N-terminal peptide of type III procollagen in serum, serum laminin and tissue collagen using a Picrosirius red dye assay. Moreover, the biochemical state of hepatocytes has been improved. The subgroups treated with octreotide in association with praziquantel revealed better results than the subgroups treated with praziquantel alone. These obtained data were analysed in terms of histological extent of liver fibrosis in sections stained with Masson trichrome and sirius red, hepatocytic and sinusoidal changes at an ultrastructural level and by immunohistochemical demarcation of endothelial cells of blood vessels through the determination of factor VIII-related antigen. The promising results detected in this study may encourage to further investigate the positive findings of this drug with the intention of its possible application on a clinical level.
AbstractList In clinical practice, octreotide (CAS 83150-76-9) has its greatest impact in the management of bleeding varices. The present work is the first one which was undertaken to investigate the possible use of octreotide as an antifibrotic agent and to study its effect on hepatic vasculature in Schistosoma mansoni infection. The material of this investigation consisted of two groups of albino mice (A, B), subdivided each into normal control, infected control, subgroups treated with octreotide, praziquantel (CAS 55268-74-1), and a combination of octreotide and praziquantel. Groups A and B were sacrificed at the 8th week and the 18th week post infection, respectively. By analysis of the obtained results, octreotide induced a reduction of the portal pressure, the weight of the spleen and the liver, the liver egg load (number of eggs) granuloma size and cellularity, and of the degree of hepatic fibrosis quantified by serum N-terminal peptide of type III procollagen in serum, serum laminin and tissue collagen using a Picrosirius red dye assay. Moreover, the biochemical state of hepatocytes has been improved. The subgroups treated with octreotide in association with praziquantel revealed better results than the subgroups treated with praziquantel alone. These obtained data were analysed in terms of histological extent of liver fibrosis in sections stained with Masson trichrome and sirius red, hepatocytic and sinusoidal changes at an ultrastructural level and by immunohistochemical demarcation of endothelial cells of blood vessels through the determination of factor VIII-related antigen. The promising results detected in this study may encourage to further investigate the positive findings of this drug with the intention of its possible application on a clinical level.
Author Yehia, H A
Hassan, E A
Youssef, M M
Hassan, M M
Hadi, A A
Mackenzie, C D
Mansy, S S
Author_xml – sequence: 1
  givenname: S S
  surname: Mansy
  fullname: Mansy, S S
  organization: Department of Electron Microscopy, Theodor Bilharz Research Institute, Imbaba Guiza, Egypt
– sequence: 2
  givenname: H A
  surname: Yehia
  fullname: Yehia, H A
– sequence: 3
  givenname: M M
  surname: Hassan
  fullname: Hassan, M M
– sequence: 4
  givenname: E A
  surname: Hassan
  fullname: Hassan, E A
– sequence: 5
  givenname: M M
  surname: Youssef
  fullname: Youssef, M M
– sequence: 6
  givenname: A A
  surname: Hadi
  fullname: Hadi, A A
– sequence: 7
  givenname: C D
  surname: Mackenzie
  fullname: Mackenzie, C D
BackLink https://www.ncbi.nlm.nih.gov/pubmed/9748716$$D View this record in MEDLINE/PubMed
BookMark eNotj81KAzEURrOo1Lb6CEJeYCC5kzTJTin1Bwrd6LpkknudSGcyTOKib69iVx-HAwe-NVuMecQFWwkhVKOkgVu2LuVLCBDGyCVbOqOskdsVe9wTYag8E8-hzphrisjzyGuPfPK1z-f8efnTPf5iCryEPpWaSx6SL6ncsRvy54L3192wj-f9--61ORxf3nZPh2aCVtdGS43GtcqhhdYG0GiFkxABqTNb1bVaa1SCvKMY0ZKxnYzklI4YlUUNG_bw352-uwHjaZrT4OfL6foEfgCpJUYP
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
ExternalDocumentID 9748716
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0R~
36B
3O-
4.4
53G
5RE
ABCQX
ABJNI
ACGFS
AEIGU
ALMA_UNASSIGNED_HOLDINGS
CGR
CUY
CVF
EBS
ECM
EIF
EJD
EMB
EMOBN
F5P
H13
L7B
MK0
NPM
O9-
P2P
RTC
SJN
SV3
X7J
ZGI
ID FETCH-LOGICAL-p235t-515e79349e8238c25e80912d2efb764b3555e40fa9fdde8f78b1df945ded48e52
ISSN 0004-4172
IngestDate Sat Sep 28 07:35:35 EDT 2024
IsPeerReviewed false
IsScholarly false
Issue 8
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p235t-515e79349e8238c25e80912d2efb764b3555e40fa9fdde8f78b1df945ded48e52
PMID 9748716
ParticipantIDs pubmed_primary_9748716
PublicationCentury 1900
PublicationDate 1998-08-01
PublicationDateYYYYMMDD 1998-08-01
PublicationDate_xml – month: 08
  year: 1998
  text: 1998-08-01
  day: 01
PublicationDecade 1990
PublicationPlace Germany
PublicationPlace_xml – name: Germany
PublicationTitle Arzneimittel-Forschung
PublicationTitleAlternate Arzneimittelforschung
PublicationYear 1998
SSID ssj0020771
Score 1.3115757
Snippet In clinical practice, octreotide (CAS 83150-76-9) has its greatest impact in the management of bleeding varices. The present work is the first one which was...
SourceID pubmed
SourceType Index Database
StartPage 855
SubjectTerms Animals
Blood Vessels - parasitology
Blood Vessels - pathology
Collagen - metabolism
Drug Synergism
Female
Liver - blood supply
Liver - drug effects
Liver - parasitology
Liver - pathology
Liver Cirrhosis, Experimental - metabolism
Liver Cirrhosis, Experimental - parasitology
Liver Cirrhosis, Experimental - pathology
Liver Function Tests
Mice
Mice, Inbred Strains
Octreotide - pharmacology
Praziquantel - pharmacology
Schistosomiasis mansoni - parasitology
Schistosomiasis mansoni - pathology
Schistosomicides - pharmacology
Title Effect of octreotide on the pathology of hepatic schistosomiasis
URI https://www.ncbi.nlm.nih.gov/pubmed/9748716
Volume 48
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Pa8IwFA5zY-Bl7JfsNzkMTxa0pia9TZzSi0OYg-0kTfOKwmzF6sH99XttYtsJY9thl1KSUEq-5OV7L3lfCLmXuGS4DnAr6LQCiwnZslyZXmamGHMUehB-ttHuPfOnV_HYZ_3tlfDo9edl_4o0liHWaebsH9DOP4oF-I6Y4xNRx-evcDdyxMgB42C1hHg1U2B2BFIR1anWXMoo4iJTa0X3NpUXSOL5zE9mSZmtdpcfEaQZUCt4twbxEpuuzUqXBbGjRJ8UK-KnbzDVp2-9IkjqIT_XYdZhKfaaF_ZNS1Xk4olt6GFrTpnFWvyLOWWiNGxEyTYKrcdbwmAxz0BAlyZ1236s3BHGNjUVUkGWkxLh3jB3tZucm7sS9Q9WyaFpvuM-ZDRifEyODP-nXQ3cCdmD6JTUR1pAfNOg4yIfLmnQOh0V0uKbM_Kg0aVxSAt0aRxRRJfm6KbVBl26g-45eRn0xz3PMndgWAu77awspJuAJpS5IJBcBbYDAhmerWwIJe8wiXTRAdYMfTfEhUqEHGebCl2cZ6CYAMeukf0ojuCCUAVcddogHSnRcju2K8KOEjxQvgLpuuyS1HTPTBZa6GRiuuzqu4prUi2GxQ05CHEOwS2pJGp9l-HxCZRLQBQ
link.rule.ids 782
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+octreotide+on+the+pathology+of+hepatic+schistosomiasis&rft.jtitle=Arzneimittel-Forschung&rft.au=Mansy%2C+S+S&rft.au=Yehia%2C+H+A&rft.au=Hassan%2C+M+M&rft.au=Hassan%2C+E+A&rft.date=1998-08-01&rft.issn=0004-4172&rft.volume=48&rft.issue=8&rft.spage=855&rft_id=info%3Apmid%2F9748716&rft_id=info%3Apmid%2F9748716&rft.externalDocID=9748716
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0004-4172&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0004-4172&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0004-4172&client=summon